Navigation Links
Pharmasset Reports Positive Results from its HCV Clinical Programs
Date:1/6/2011

gic collaboration with Roche. Our other clinical stage HCV candidates include PSI-7977, an unpartnered uracil nucleotide analog that is in two Phase 2b studies in patients with HCV genotypes 1, 2, or 3, and PSI-938, an unpartnered guanine nucleotide analog which has completed a 14-day monotherapy study and has recently initiated a 14-day combination study with PSI-7977. We also have in our pipeline an additional purine nucleotide analog, PSI-661, in advanced preclinical development.

Pegasys(R) and Copegus(R) are registered trademarks of Roche. ContactRichard E. T. Smith, Ph.D.VP, Investor Relations and Corporate CommunicationsOffice +1 (609) 613-4181 Forward-Looking StatementsPharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:  Statements in this press release that are not historical facts are "forward-looking statements," that involve risks, uncertainties, and other important factors, including, without limitation,  the risk of cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates,  the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful, and the risk that any one or more of our product candidates will not be successfully developed and commercialized.  For a discussion of risks, uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 30, 2010 filed with the Securities and Exchange Commission and discussions of potential risks, uncertainties, and other important factors in our subsequent filings with the Se
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... November 26, 2014 A hernia is ... organ protrudes through the wall of a weak muscle area. ... birth are some of the causes of hernias. There are ... and incisional. An inguinal hernia is when part of the ... is found in the area of the umbilicus. A hiatal ...
(Date:11/26/2014)... 2014  Aridis Pharmaceuticals, Inc., a biopharmaceutical company ... infectious diseases, announced today the addition of ... opinion leader in the areas of pneumonia and ... Founder and Chief Executive Officer, Vu ... extensive experience investigating bacterial toxins and key mechanisms ...
(Date:11/26/2014)... , November 25, 2014 ... Market by Power Source (Electric, Battery, Pneumatic), by ... Blade, Burr, Cart), by Application (Orthopedic, ENT, Oral, ... by MarketsandMarkets, the global Powered Surgical Instruments Market is ... Billion in 2014 and is expected to grow ...
Breaking Medicine Technology:Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4
... 2011 Heska Corporation (Nasdaq: HSKA ) today ... by Sidoti & Company, LLC on Monday, January 10, 2011 ... (Park Avenue at Grand Central) in New York City.  The ... (Logo:   http://photos.prnewswire.com/prnh/20000622/HESKALOGO ) ...
... Gliknik Inc ., a biopharmaceuticals company creating ... equity financing completed at a premium price. In the ... in equity financing. Gliknik expects to use the funds to ... lead recombinant candidate from its first-in-class stradomer™ platform. ...
Cached Medicine Technology:Gliknik Announces Completion of Equity Financing 2
(Date:11/28/2014)... Miami, FL (PRWEB) November 28, 2014 ... over 6,100 hot meals to needy individuals and families ... This is the largest meal delivery effort in Florida ... on Thanksgiving morning at 8 by putting together individual ... volunteer drivers who delivered them. Each meal includes turkey, ...
(Date:11/28/2014)... November 28, 2014 Pathways Home ... 2, 2014. This national movement was created to encourage ... giving to local charities and causes. This online ... with the kickoff of the holiday shopping season. #GivingTuesday ... shopping and Cyber Monday is to online commerce. , ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Junk-A-Car ( ... is expanding their service offerings to help drivers, especially ... Philadelphia and Washington, D.C. metropolitan areas deal with the ... across a large part of the country. , With ... resulting in hundreds of totaled, crashed and junk ...
(Date:11/28/2014)... York (PRWEB) November 28, 2014 ... to move forward in New Jersey’s Bergen County ... a consolidated litigation established there is quickly approaching ... updated on November 18th shows 1,293 lawsuits now ... for lawsuits that allege complications resulting from spontaneous ...
(Date:11/28/2014)... Dr. Paul Vitenas, one of the most awarded ... Holiday Event for those in the area that would like to ... & Glow will take place on December 11, 2014, from 6:00 ... heart of Houston at 4208 Richmond Ave. , “We want ... will come and celebrate the season with us on December 11, ...
Breaking Medicine News(10 mins):Health News:Branches’ 14th Annual Thanksgiving Delivers 6,000+ Meals to Families in Need 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3Health News:Junk-A-Car Expanding Service to Assist U.S. Car Owners That May be Affected by Severe Winter Storms 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3
... , RESEARCH TRIANGLE PARK, N.C., Sept. 21 ... standards for funding accredited, continuing medical education (CME) for healthcare ... Starting in 2010, GSK will raise the bar and ... to close gaps in patient care, and that demonstrate support ...
... ... TCO by Streamlining IT Audit Processes, Harmonizing Controls with Policy Requirements, and Providing Greater IT ... ... , , ,News Facts:, , ,A typical organization spends 30-50% more on compliance and IT ...
... , LOS ANGELES, Sept. 21 ... nationally as the "Dean of DUI Attorneys", claims that many citizens ... alcohol (DUI) are actually innocent. Their crime: diabetes. , ... Drunk Driving Defense , claims that the symptoms of a ...
... , , , ... economic downturn and reduction in funding for early stage projects ... across major therapeutic segments in the short-to-medium term. However, due ... and biotechnology companies will invest in in-house capabilities to conduct ...
... may suffer from dementia , MONDAY, Sept. 21 (HealthDay ... a rapid pace, and by next year 35.6 million people ... percent increase since 2005, a new report predicts. , ... 65.7 million in 2030 and 115.4 million in 2050, ...
... , , SAN JOSE, Calif., ... of Motorola, Inc. (NYSE: MOT ), ... partner, has deployed its 802.11n wireless LAN (WLAN) solution ... located in Ludington, Mich. , , Motorola,s innovative ...
Cached Medicine News:Health News:GSK Limits Medical Education Funding to Independent Programs With Highest Impact on Patient Care 2Health News:GSK Limits Medical Education Funding to Independent Programs With Highest Impact on Patient Care 3Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 2Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 3Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 4Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 5Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 6Health News:Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance 7Health News:Los Angeles DUI Attorney Claims Diabetics Often Falsely Convicted of Drunk Driving 2Health News:Frost & Sullivan: Key Therapeutic Areas to Remain Strongest Drivers of CRO Revenue Growth in the United States 2Health News:Frost & Sullivan: Key Therapeutic Areas to Remain Strongest Drivers of CRO Revenue Growth in the United States 3Health News:Alzheimer's Soars, Global Focus Needed: Study 2Health News:Alzheimer's Soars, Global Focus Needed: Study 3Health News:Motorola's 802.11n Wireless LAN Solution Improves Patient Care and Wireless Security at Memorial Medical Center of Western Michigan 2Health News:Motorola's 802.11n Wireless LAN Solution Improves Patient Care and Wireless Security at Memorial Medical Center of Western Michigan 3Health News:Motorola's 802.11n Wireless LAN Solution Improves Patient Care and Wireless Security at Memorial Medical Center of Western Michigan 4Health News:Motorola's 802.11n Wireless LAN Solution Improves Patient Care and Wireless Security at Memorial Medical Center of Western Michigan 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: